Xconomy National

Archives

by in

Entry	Author	Date	Location
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups	Luke Timmerman	12/22/11	Seattle
Oncothyreon CEO Bob Kirkman Returns from Medical Leave	Luke Timmerman	12/02/11	Seattle
Chris Henney, the Immunex and Dendreon Mover/Shaker, Makes Biotech Hall of Fame	Luke Timmerman	10/17/11	Seattle
The Immunex Impact: Join Steve Gillis, Chris Henney and Many More on Dec. 1	Luke Timmerman	09/15/11	Seattle
Dendreon Slashes 500 Jobs, Gates Foundation Adds Novartis Exec, Theraclone Tacks on $10M, & More Seattle-Area Life Sciences News	Luke Timmerman	09/15/11	Seattle
Oncothyreon CEO Bob Kirkman Takes Leave, Chairman Chris Henney to Fill In	Luke Timmerman	09/08/11	Seattle
Kleiner Perkins’ Bet on a Concrete Stomach, The Gates Foundation’s Out-of-the-Box Ideas, & More Seattle-Area Life Sciences News	Luke Timmerman	05/05/11	Seattle
Oncothyreon Tacks On $40M	Luke Timmerman	04/29/11	Seattle
Omeros Flunks Pivotal Trials, Dendreon’s Shareholder Hubbub, AVI Biopharma Nabs $30M, & More Seattle-Area Life Sciences News	Luke Timmerman	04/07/11	Seattle
Oncothyreon Starts Phase 2 Trial	Luke Timmerman	04/05/11	Seattle
Dendreon Adds $80M, Amgen Advances ‘Son of Dmab,’ Mobisante Wins FDA OK, & More Seattle-Area Life Sciences News	Luke Timmerman	02/10/11	Seattle
Oncothyreon Secures $12.5M Loan	Luke Timmerman	02/09/11	Seattle
Seattle Genetics’ Home Run, Acucela Growing Ties to Japan, Calistoga’s Wall Street Guy, & More Seattle-Area Life Sciences News	Luke Timmerman	09/30/10	Seattle
Oncothyreon Raises $14.9M	Luke Timmerman	09/24/10	Seattle
Who Will Pay For Innovation in the 21st Century? Find Out at Xconomy “VC Crossfire” Oct. 28	Luke Timmerman	09/09/10	Seattle
Washington Startups Bring in $81.7M in July, Majority in Healthcare Sector	Thea Chard	08/27/10	Seattle
Amazon’s Vision for Biology in the Cloud, Uptake Nabs $17.5M, CMC Icos Mounts Comeback, & More Seattle-Area Life Sciences News	Luke Timmerman	07/08/10	Seattle
Oncothyreon Lines Up $20M	Luke Timmerman	07/07/10	Seattle
Seattle Genetics’ Dark Horse, Gilead Beats Novartis, Oncothyreon Back in the Saddle, & More Seattle-Area Life Sciences News	Luke Timmerman	06/24/10	Seattle
Oncothyreon’s Cancer Vaccine Back in the Saddle, as Merck KGaA Re-Starts Clinical Trials	Luke Timmerman	06/17/10	Seattle
Calistoga Pharmaceuticals Builds Stronger Case for Blood Cancer Drug	Luke Timmerman	06/07/10	Seattle
Dendreon Makes History: FDA Approves First Active Immune-Booster to Fight Cancer	Luke Timmerman	04/29/10	Seattle
FDA Panel Slams Cell Therapeutics, Oncothyreon Slumps, Biotech’s Healthcare Victory, & More Seattle-Area Life Sciences News	Luke Timmerman	03/25/10	Seattle
Oncothyreon Stock Plummets as Side Effect Emerges in Cancer Patient, Trials Halted	Luke Timmerman	03/23/10	Seattle
Cell Therapeutics Dangles Exec Bonuses, Oncothyreon’s Turnaround Year, VLST Layoffs, & More Seattle-Area Life Sciences News	Luke Timmerman	12/24/09	Seattle
Oncothyreon CEO on Next-Generation Cancer Vaccines, Two Key Zymonites, and Serious Luck	Luke Timmerman	12/23/09	Seattle
Dendreon Nails Down $409M, Stewart Parker Gets Itch to Return, Seattle Genetics Finds New Partner, & More Seattle-Area Life Sciences News	Luke Timmerman	12/17/09	Seattle
From Russia With Love (for Biotech), Stewart Parker Gets “Antsy” to Return	Luke Timmerman	12/14/09	Seattle
Oncothyreon Partner Starts New Lung Cancer Trial, Prompts Takeover Scuttle	Luke Timmerman	12/10/09	Seattle
The Icos Alumni Guide, Trubion CEO Resigns, OVP Leads $30M Fate Deal, & More Seattle-Area Life Sciences News	Luke Timmerman	11/19/09	Seattle
Page 1 of 2	next page »